1. Home
  2. SPIR vs XNCR Comparison

SPIR vs XNCR Comparison

Compare SPIR & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spire Global Inc.

SPIR

Spire Global Inc.

HOLD

Current Price

$18.27

Market Cap

826.5M

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$14.92

Market Cap

937.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPIR
XNCR
Founded
2012
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
826.5M
937.1M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
SPIR
XNCR
Price
$18.27
$14.92
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$16.40
$22.33
AVG Volume (30 Days)
1.4M
925.9K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
134.98
65.36
EPS
N/A
N/A
Revenue
$110,451,000.00
$125,576,000.00
Revenue This Year
$12.31
N/A
Revenue Next Year
$22.63
$4.80
P/E Ratio
N/A
N/A
Revenue Growth
13.15
13.65
52 Week Low
$6.60
$6.92
52 Week High
$25.93
$18.69

Technical Indicators

Market Signals
Indicator
SPIR
XNCR
Relative Strength Index (RSI) 50.07 63.27
Support Level $15.46 $10.94
Resistance Level $20.15 $15.59
Average True Range (ATR) 1.65 0.84
MACD 0.08 0.24
Stochastic Oscillator 57.66 60.55

Price Performance

Historical Comparison
SPIR
XNCR

About SPIR Spire Global Inc.

Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: